TERT and neoplasm: Up to 50% of HCCs were previously reported to have TERT promoter mutations, and those studies showed an association of the mutation with certain clinico-pathological variables including age, sex, HBV or HCV infection, α-fetoprotein, tumor sizes/numbers, differentiation status and metastasis [2, 9–16].